The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
The product will be marketed by Dr. Reddy's
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Subscribe To Our Newsletter & Stay Updated